Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15226 | 0.96 | — | — | |
| SCHEMBL1127507 | 0.96 | — | — | |
| SCHEMBL1217603 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL3718561 | 0.92 | — | — | |
| Water SCHEMBL2274834 | 0.92 | TSHR (0.47) | — | |
| SCHEMBL8605179 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL4345954 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL1189441 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL1550394 | 0.92 | — | — | |
| Fluoride SCHEMBL1055335 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023147478-A2 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF ADMINISTRATION | METASTX, LLC (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023050003-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2023-04-06 | — | — | WO | disclosed |
| EP-2386551-A1 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | Fasgen Inc. (US) | 2011-11-16 | — | — | EP | disclosed |
| EP-2386550-A1 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | Fasgen Inc. (US) | 2011-11-16 | — | — | EP | disclosed |
| US-D647106-S1 | Display module for an electronic device | APPLE INC. (US) | 2011-10-18 | — | — | US | disclosed |
| US-8038089-B2 | Leader member in recording tape cartridge, manufacturing method thereof, and recording tape cartridge | FUJIFILM CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20100120901-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN,INC (US) | 2010-05-13 | — | — | US | disclosed |
| US-7649012-B2 | Compounds, pharmaceutical compositions containing same, and methods of use for same | FASGEN, INC. (US) | 2010-01-19 | — | — | US | disclosed |
| EP-1539730-A4 | NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN INC (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20060247302-A1 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | FASGEN, INC. (US) | 2006-11-02 | — | — | US | disclosed |
| EP-1539730-A1 | NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | Fasgen Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004005277-A1 | NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN, INC. (US) | 2004-01-15 | — | — | WO | disclosed |